Provati Insurance PLC. announcements
394 Dhaka Stock Exchange announcements for Provati Insurance PLC. (PROVATIINS) since 2010: results, dividends, board meetings, AGMs, record dates and other price-sensitive information. Showing 2022 (17).
- Q3 Financials
(Q3 Un-audited): EPS was Tk. (0.33) for July-September, 2022 as against Tk. 1.12 for July-September, 2021; EPS was Tk. 1.33 for January-September, 2022 as against Tk. 2.94 for January-September, 2021. NOCFPS was Tk. 0.94 for January-September, 2022 as against Tk. 4.68 for January-September, 2021. NAV per share was Tk. 19.49 as on September 30, 2022 and Tk. 20.98 as on September 30, 2021.
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 17, 2022 at 2:30 PM to consider, among others, un-audited financial statements of the company for the Third Quarter (Q3) period ended September 30, 2022.
- ARGUS Credit Rating Services Limited (ACRSL) has announced the CPA rating of the Company as \"AAA\" for long term and \"
ARGUS Credit Rating Services Limited (ACRSL) has announced the CPA rating of the Company as \"AAA\" for long term and \"ST-2\" for short term in consideration of financials of the Company up to December 31, 2021 (audited), Q2FY22 (unaudited) and other relevant quantitative as well as qualitative information up to the date of rating declaration.
- Dividend Disbursement
The Company has informed that it has disbursed the cash dividend for the year ended December 31, 2021 to the respective shareholders' Bank Accounts.
- Dividend Disbursement
The Company has informed that it has credited the Bonus shares for the year ended December 31, 2021 to the respective shareholders' BO Accounts.
- Q2 Financials
(Q2 Un-audited): EPS was Tk. 0.54 for April-June 2022 as against Tk. 0.74 for April-June 2021; EPS was Tk. 1.93 for January-June 2022 as against Tk. 1.82 for January-June 2021. NOCFPS was Tk. 2.47 for January-June 2022 as against Tk. 4.09 for January-June 2021. NAV per share was Tk. 23.99 as on June 30, 2022 and Tk. 19.86 as on June 30, 2021.
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on July 20, 2022 at 7:30 PM to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended June 30, 2022.
- Resumption after record date
Trading of the shares of the company will resume on 31.05.2022 after record date.
- Suspension for Record date
Trading of the shares of the company will remain suspended on record date i.e. 30.05.2022.
- Spot News
Trading of the shares of the company will be allowed only in the Spot Market and Block transaction will also be settled as per spot settlement cycle with cum benefit from 26.05.2022 to 29.05.2022 and trading of the shares will remain suspended on record date i.e., 30.05.2022.
- The Board of Directors has recommended 10\% cash and 16\% stock dividend for the year ended December 31, 2021. Date of A
The Board of Directors has recommended 10\% cash and 16\% stock dividend for the year ended December 31, 2021. Date of AGM: 20.07.2022, Time: 11:00 AM, Venue: Digital Platform. Record Date: 30.05.2022. The Company has also reported EPS of Tk. 4.30, NAV per share of Tk. 22.34 and NOCFPS of Tk. 7.07 for the year ended December 31, 2021 as against Tk. 3.10, Tk. 21.11 and Tk.10.72 respectively for the same period of the previous year. (cont.)
- Agreed to purchase shares of Trading Company and Hospital
The Board of Directors of the company agreed to purchase 63% Shares of Al-Muntaha Trading Company Limited, DSE TREC No. 049 at price of Tk. 29 crore and 65% shares of Reliance General & Renal Hospital, address: 214 Kathal Bagan, Green Road, Dhaka at a price of Tk. 6.5 crore subject to the approval by the Regulatory Authority.
- Price Limit Open
There will be no price limit on the trading of the shares of the Company today (05.05.2022) following its corporate declaration.
- Dividend Declaration
(Continuation news of PROVATIINS): The Company also informed that i) As per Schedule-1, Section 21 of the Insurance Act 2010, every Non-life Insurance should have forty crore of Paid-up Capital. At present paid-up Capital is Tk. 34,75,19,290.00 only. So, The Company has declared 16% stock dividend for this year. ii) The bonus share is not declared from capital reserve or revaluation reserve or any kinds other than accumulate profit. (end)
The first part of this announcement is missing from the archive. - Q1 Financials
(Q1 Un-audited): EPS was Tk. 1.38 for January-March 2022 as against Tk. 1.26 for January-March 2021. NOCFPS was Tk. 2.80 for January-March 2022 as against Tk. 2.54 for January-March 2021. NAV per share was Tk. 23.45 as on March 31, 2022 and Tk. 22.34 as on March 31, 2021.
- Board Meeting schedule under LR 19(1)
As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 28, 2022 at 2:30 PM to consider, among others, audited financial statements of the Company for the year ended December 31, 2021.
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 28, 2022 at 2:30 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended March 31, 2022.
Source: Dhaka Stock Exchange announcements. Some posts before 2014 have no title, and 2014–2020 coverage is incomplete.